Article
Mutation of the androgen receptor at amino acid 708 (Gly-->Ala) abolishes partial agonist activity of steroidal antiandrogens.
Molecular pharmacology - 1 Apr 2003
Terouanne Béatrice, Nirdé Philippe, Rabenoelina Fanja, Bourguet William, Sultan Charles, Auzou Gilles
Abstract excerpt
Mutation of a single amino acid in the ligand-binding domain (LBD) of the human androgen receptor (hAR) can induce functional abnormalities in androgen binding, stabilization of active conformation, or interaction with coactivators. The Gly708Ala and Gly708Val substitutions are associated with partial and complete androgen insensitivity syndromes, respectively. In this work, we introduced Ala, Val, and aromatic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
